Literature DB >> 12818519

Cytoskeletal motors and cargo in membrane trafficking: opportunities for high specificity in drug intervention.

Mitch A Phelps1, Amy B Foraker, Peter W Swaan.   

Abstract

Membrane trafficking comprises the directed transport of vesicle and/or organelle cargos to specific locations throughout the cell, and is primarily driven by molecular motors tracking along microtubules and microfilaments. The mechanisms by which specific motor complexes attach to their respective vesicular cargo is of great interest, and is only now starting to be unraveled. The proteins identified as links between the molecular motors and the vesicular cargo are viable drug targets and represent opportunities to regulate small groups of related proteins or even single proteins, such as receptors and transporters, at the cytosolic trafficking level. Ultimately, continued development in this area will lead to greater success in directing endocytosed drugs to the desired intracellular targets, such as the cell nucleus or the basolateral membrane.

Mesh:

Substances:

Year:  2003        PMID: 12818519     DOI: 10.1016/s1359-6446(03)02707-7

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  4 in total

1.  RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure.

Authors:  Michael Carleton; Mao Mao; Matthew Biery; Paul Warrener; Sammy Kim; Carolyn Buser; C Gary Marshall; Christine Fernandes; James Annis; Peter S Linsley
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 2.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

3.  Kinesin 5B (KIF5B) is required for progression through female meiosis and proper chromosomal segregation in mitotic cells.

Authors:  Dawit Kidane; Denny Sakkas; Timothy Nottoli; James McGrath; Joann B Sweasy
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

4.  High expression of KIF26B in breast cancer associates with poor prognosis.

Authors:  Qun Wang; Zong-Bin Zhao; Geng Wang; Zhen Hui; Ming-Hua Wang; Jun-Feng Pan; Hong Zheng
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.